Practice Areas & Industries: Duane Morris LLP

 




Products Liability and Toxic Torts Return to Practice Areas & Industries

Group Profile Lawyers in this Group Offices Locations for this Group
 

Practice/Industry Group Overview

Clients, ranging from some of the world's largest manufacturers and insurance companies to startup companies and individual inventors, turn to Duane Morris for counsel and representation regarding products liability and toxic torts. Duane Morris has for many years worked with clients to develop cost containment and strategic litigation plans resulting in high-level representation without fear of wildly escalating costs.

Duane Morris has many lawyers with extensive trial experience in the products liability and toxic torts arenas. As one of the 100 largest law firms in the world, Duane Morris utilizes industry-leading technology and IT professionals to efficiently and effectively handle client data needs through secure extranets and other means. In addition, our firm's breadth of capabilities and geographic footprint help us to assist clients with issues touching a range of legal disciplines in jurisdictions across the United States and around the world.

Duane Morris' experience includes product class actions, mass tort defense, and service on clients' national trial teams in federal, state and multidistrict litigation. In fact, we serve as National Coordinating Counsel (NCC) for huge, multinational manufacturers, and our lawyers have been published and quoted on best practices regarding the use of NCC.

The firm has working relationships with an extensive group of well qualified, independent and trial-tested consultants and expert witnesses, as well as experience in developing experts, and handling Daubert and Frye hearings in multiple jurisdictions. Our trial lawyers also work arm-in-arm with our Appellate Practice Group to provide sophisticated approaches to appellate issues faced by our clients in products liability matters.


 

Services Available

Our lawyers have defended a wide variety of products manufactured, distributed, sold or insured by our clients. We also counsel clients on regulatory, labeling, packaging and marketing issues to help manage risk and avoid litigation. We advise clients on product safety compliance, reporting, recalls and penalty proceedings before the U.S. Consumer Product Safety Commission (CPSC), the Food and Drug Administration (FDA) and their state counterparts, and other regulatory agencies.

Range of Experience

Areas in which our attorneys have experience include:

Food, Drugs and Medical Devices

  • Pharmaceuticals
  • Vitamins
  • Dietary supplements
  • Diet drugs
  • Medical devices
  • Surgical implants
  • Surgical tools
  • Orthopedic devices
  • Hospital equipment and medical supplies
  • Clinical and genetic laboratory testing
  • Dental devices and equipment
  • Food and food processing

Consumer Products

  • Sporting goods
  • Recreational equipment
  • Toys
  • Weapons and body armor
  • Hair care and cosmetics
  • Cleansers
  • Clothing

Toxic Torts

  • Asbestos
  • Silica
  • Amorphous silica
  • Benzene
  • Pesticides
  • Mold
  • Chemicals, paints and coatings
  • Cleaners and degreasers
  • Ground Water Contamination

Vehicles and Equipment

  • Automobiles, trucks and their components
  • Landscaping and grounds maintenance equipment
  • Energy generation equipment
  • Construction and farm equipment
  • Printing equipment
  • Heating equipment
  • Industrial equipment

 
 
Articles Authored by Lawyers at this office:

New Jersey Trial Court Grants Summary Judgment in Accutane Mass Tort Cases
James J. Ferrelli, April 14, 2015
In an opinion issued on April 2, 2015, the Honorable Nelson C. Johnson, JSC, granted the motion of defendants Hoffmann-LaRoche, Inc. and Roche Laboratories, Inc. for summary judgment in the In re Accutane Multicounty (mass tort) Litigation (MCL) on the grounds that the defendants' post-April 2002...

Drug Quality and Security Act Does Not Apply to Veterinary Compounding
Patrick C. Gallagher,Rachael G. Pontikes,Alison T. Rosenblum, March 30, 2015
While the Drug Quality and Security Act (DQSA) provided a new regulatory framework for compounded medications for use in human medicine, it does not apply to veterinary compounded medications. There has been some confusion in the industry, but veterinary compounded medications are still regulated...

FDA Establishes the Office of Pharmaceutical Quality
, March 03, 2015
In a press conference earlier this year, Dr. Janet Woodcock, head of the U.S. Food and Drug Administration's (FDA) pharmaceutical division, stated that the FDA has been working on "establish[ing] consistent quality standards for all drugs, whether brand name or generic" over the past 10...

FDA Issues Additional Guidances on Implementation of Drug Supply Chain Security Act
, March 03, 2015
The U.S. Food and Drug Administration (FDA) continues to publish draft guidance implementing the Drug Supply Chain Security Act (DSCSA). This Alert highlights key facts on three recent draft Guidance for Industry, which focus on: interoperable exchange of information, annual reporting by wholesale...

Pennsylvania Supreme Court Adopts New Standards for Strict Liability Claims
, February 17, 2015
On November 19, 2014, the Pennsylvania Supreme Court issued its much-anticipated decision in Tincher v. Omega Flex, Inc. (No. 17 MAP 2013), in which it addresses the proper standard under Pennsylvania law for strict liability claims relating to allegedly defective products. Although the court...

FDA Publishes Second Draft Guidance for Further Clarification of Drug Supply Chain Security Act
Carolyn A. Alenci,Frederick R. Ball, December 10, 2014
Earlier this year, the U.S. Food and Drug Administration (FDA) requested information and commentary for the implementation of the Drug Supply Chain Security Act (DSCSA) that in part "establishes a Federal system for tracing prescription drug products through the pharmaceutical distribution...

FDA Issues Draft Guidance for Identification and Notification of Suspect Products
, July 08, 2014
As discussed in our April 11, 2014 Alert, the Drug Supply Chain Security Act (DSCSA) was enacted "to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed within the United States." Recently, the U.S. Food and Drug...

FDA Releases Guidance for Industry on ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers
, July 08, 2014
The U.S. Food and Drug Administration (FDA) recently published a new Guidance for Industry, titled ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers, which provides answers to questions from public comments received on the draft Guidance for Industry on ANDAs:...